Month: September 2014

Alabama Graphite Reports 54.7% Large and Jumbo Flake Graphite with Purities Ranging from 96.3% to 98.5% at its Bama Property

Alabama Graphite Corp. (“Alabama Graphite” or the “Company”) (ALP) (otcqx:ABGPF) (frankfurt:1AG WKN) (ISIN# CA0102931080) is pleased to announce that it has received the first set of metallurgical results from SGS Laboratory in Lakefield, Ontario, Canada on sample material originating from the newly acquired Bama Property. Using only simple floatation (without chemical or thermal treatment) the Bama composite sample produced a graphite concentrate that contained an aggregate of 54.7% large flake (+80 mesh), of which 17.8% was in the jumbo flake (+48 mesh) category. For all size ranges coarser than +150 mesh the purity exceeded 96.3% with the jumbo flake fraction having a purity of 98.5% in Scoping Level Evaluations. Click Here

Alabama Graphite Acquires Prior Producing Bama Flake Graphite Mine in Chilton County, Alabama, USA

Vancouver, BC / TNW-ACCESSWIRE / September 18, 2014 / Alabama Graphite Corp. (the “Company”) (TSX-V:ALP) (OTCQX:ABGPF) (FRANKFURT: 1AG WKN: A1J35M) (ISIN# CA0102931080) is pleased to announce that it has entered into a mineral lease on a land package that includes the prior producing Bama flake graphite Mine in Chilton County, Alabama, USA. The mineral lease comprises 200 acres and includes both the surface as well as the mineral rights over the historic Bama Mine. Click Here

Alabama Graphite Reports Higher Grade, Near Surface (oxidized zone) Intercepts within New Geophysical Targets at its Coosa Project, Alabama, USA

Vancouver, BC / TNW-ACCESSWIRE / September 16, 2014 / Alabama Graphite Corp. (the “Company”) (TSX-V:ALP) (OTCQX:ABGPF) (FRANKFURT: 1AG WKN: A1J35M) (ISIN# CA0102931080) is pleased to report assay results from the summer 2014 sonic drilling program at its Coosa Graphite Project in Alabama, USA. Sonic drilling was chosen because of its ability to drill on established roads without extensive pad preparation as well as accommodating the Company’s desire to economically and preferentially test only the upper oxidized portions (0-65ft depth) of individual targets identified by the airborne survey completed in May, 2014. Click Here

iWallet Names Jack Chadsey CEO; Secure Luxury Techcessories Maker Appoints Retail Veteran to Top Post

iWallet Corporation (OTCQB: IWAL), the secure luxury techcessories company, has named Jack Chadsey as its new CEO. Chadsey replaces Steve Cabouli, who will continue to serve as President and a member of the Board of Directors. Chadsey’s retail career includes senior executive positions with premier retailers, including May Department Stores Company, Kohl’s, Dayton Hudson, Target and Sunglass Hut International where as President and CEO, he led the company through an IPO and a major international expansion strategy. Since leaving Sunglass Hut, Chadsey has been involved in the private retail sector providing equity capital, board representation and operating management expertise to specialty retailers. The iWallet expects to usher in a new generation of smart techcessories that leverage the latest technology, such

Continue Reading “iWallet Names Jack Chadsey CEO; Secure Luxury Techcessories Maker Appoints Retail Veteran to Top Post”

Nuvo Research® settles litigation with Mallinckrodt Pharmaceuticals

MISSISSAUGA, ON, Sept. 8, 2014 /CNW/ – Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has reached a full settlement with Mallinckrodt Inc. of Nuvo’s claims and Mallinckrodt’s counterclaim relating to Nuvo’s license to Mallinckrodt of the right to market and sell Pennsaid® and Pennsaid 2% in the United States.  Under the terms of the settlement agreement,Mallinckrodt will return all U.S. rights to Pennsaid and Pennsaid 2% to Nuvo after a brief transition period and payUS$10 million. Click Here

Nuvo Research® Completes Enrolment in WF10™ Phase 2 Clinical Trial

MISSISSAUGA, ON, Sept. 3, 2014 /CNW/ – Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has completed enrolment in its Phase 2 clinical trial to investigate the safety and efficacy of WF10 in patients with refractory allergic rhinitis.  The Company expects the trial to be completed in late 2014 with top-line results anticipated in the first quarter of 2015. Click Here

Mission Ready Services Inc.: 10-20 Wins Subcontract on $8.3M Marine Corps Award

Mission Ready Services Inc. (TSX VENTURE:MRS) – Mission Ready Services Inc. (“Mission Ready” or “MRSI” or the “Company”) is pleased to announce that, through its wholly owned subsidiary 10-20 Services Inc. (“10-20”), in a teaming arrangement with prime contractor Carl Amber Brian Isaiah And Associates (“CBAIA”), (CBAIA and 10-20 collectively “Team Barstow”), Team Barstow has been awarded under Contract/Purchase Order/Agreement No. M67004-13-D-0029 up to $8.3 million to provide warehousing and operations support services to clean and launder, stock and store up to 7,800 pallets of Individual Protective Personnel Equipment (IPPE) for the Marine Corps Logistics Systems Command (“MCLC”).  Click Here